Jacquie Ross | VP, IR |
Daniel O'Day | Chairman and CEO |
Johanna Mercier | Chief Commercial Officer |
Merdad Parsey | Chief Medical Officer |
Andrew Dickinson | CFO |
Dennis Ding | Jefferies |
Brian Abrahams | RBC |
Chris Schott | JPMorgan |
Geoff Meacham | Bank of America |
Terence Flynn | Morgan Stanley |
Umer Raffat | Evercore |
Tyler Van Buren | Cowen |
Hartaj Singh | Oppenheimer & Co |
Charlie More | RW Baird |
Ryan Deschner | Raymond James |
Olivia Brayer | Cantor Fitzgerald |
Mohit Bansal | Wells Fargo |
Hello, everyone, and welcome to the First Quarter 2023 Gilead Sciences Earnings Conference Call. My name is Nadia, and I'll be coordinating the call today. [Operator Instruction]
I will now hand over to your host, Jacquie Ross, Vice President, Investor Relations to begin. Jacquie, please go ahead.